| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 228.906 | 162.431 | 3.065 | 5.845 | 7.663 | 11.709 | 10.698 | 19.933 | 25.351 | 26.737 |
| Total Income - EUR | 229.781 | 208.045 | 5.053 | 5.845 | 7.663 | 11.709 | 10.739 | 19.934 | 25.352 | 53.055 |
| Total Expenses - EUR | 225.841 | 179.091 | 2.615 | 3.189 | 1.863 | 3.008 | 2.782 | 2.375 | 2.895 | 28.389 |
| Gross Profit/Loss - EUR | 3.940 | 28.954 | 2.438 | 2.657 | 5.799 | 8.701 | 7.956 | 17.560 | 22.457 | 24.665 |
| Net Profit/Loss - EUR | 2.590 | 23.896 | 2.287 | 2.481 | 5.569 | 8.378 | 7.657 | 16.974 | 19.289 | 24.135 |
| Employees | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Imedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.539 | 28.137 | 26.579 | 23.839 | 22.507 | 21.363 | 20.187 | 19.546 | 18.785 | 21.063 |
| Current Assets | 147.278 | 91.114 | 89.690 | 87.457 | 86.397 | 89.175 | 90.765 | 105.554 | 115.696 | 112.266 |
| Inventories | 59.199 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 114.823 | 87.622 | 86.138 | 84.595 | 84.946 | 82.266 | 80.661 | 82.242 | 81.860 | 2.503 |
| Cash | -26.744 | 3.492 | 3.552 | 2.862 | 1.451 | 6.909 | 10.104 | 23.312 | 33.836 | 109.763 |
| Shareholders Funds | 87.517 | 110.564 | 110.980 | 109.276 | 108.528 | 110.093 | 110.053 | 111.754 | 127.267 | 35.168 |
| Social Capital | 225 | 267 | 263 | 258 | 253 | 248 | 243 | 243 | 243 | 241 |
| Debts | 89.301 | 8.687 | 5.290 | 2.021 | 376 | 445 | 900 | 13.346 | 7.215 | 98.161 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Imedica Srl